...
首页> 外文期刊>Journal of Surgical Oncology >DNA hydroxymethylation of colorectal primary carcinoma and its association with survival
【24h】

DNA hydroxymethylation of colorectal primary carcinoma and its association with survival

机译:结直肠原代癌的DNA羟甲基化及其与生存结合

获取原文
获取原文并翻译 | 示例

摘要

Methods A total of 71 cases of colorectal carcinoma with hepatic metastasis were enrolled from the Department of Pathology of SIR RUN RUN SHAW Hospital. Paired primary tumors, hepatic metastases, and normal mucosa samples were collected from formalin‐fixed paraffin‐embedded tissues by manual macrodissection. And global levels of DNA methylation and hydroxymethylation in these tissues, measured by an ELISA‐like microplate‐based colorimetric methods. The immunohistochemical expression of 5‐methylcytosine and 5‐hydroxymethylcytosine were analyzed also. Results The levels of DNA methylation in both primary and metastatic tumors were elevated when compared with normal mucosa, while DNA hydroxymethylation decreased slightly in those tissues. Similar results were observed in immunohistochemical staining. DNA methylation in hepatic metastases differed significantly in lymph node metastases ( P ?=?0.037). And DNA hydroxymethylation in colorectal primary carcinoma was significantly different between tumor grade group ( P ?=?0.018) and gender group ( P ?=?0.048) respectively. And survival analyzes revealed that higher levels DNA hydroxymethylation were associated with better prognosis in colorectal primary carcinoma ( P ??0.05). Conclusion DNA hydroxymethylation correlated with less aggressive tumor behavior in colorectal cancer and were identified as an independent prognostic factor in patients' overall survival, and downregulation of DNA hydroxymethylation may serve as a useful biomarker for colorectal cancer prognosis evaluation.
机译:方法从先生跑龙医院的病理处注册了肝转移的71例结直肠癌癌。通过手动大分子从福尔马林固定的石蜡包埋组织收集配对的原发性肿瘤,肝转移和正常的粘膜样品。在这些组织中的DNA甲基化和羟甲基甲基化的全球水平,通过基于ELISA样微孔层的比色方法测量。分析了5-甲基胞嘧啶和5-羟甲基胞嘧啶的免疫组织化学表达。结果与普通粘膜相比,初级和转移性肿瘤中DNA甲基化水平升高,而DNA羟甲基在这些组织中略微下降。在免疫组织化学染色中观察到类似的结果。肝转移中的DNA甲基化在淋巴结转移中有显着不同(P?= 0.037)。在肿瘤级基团(P?= 0.018)和性别组(P?= 0.048)之间的结直肠原代癌中的DNA羟甲基甲基化显着差异。生存分析表明,较高水平的DNA羟甲基甲基化与结肠直肠原癌的更好预后有关(P?& 0.05)。结论DNA羟甲基甲基化与结直肠癌中较少的侵袭性肿瘤行为相关,并被鉴定为患者总存活的独立预后因素,DNA羟甲基甲基化的下调可作为结直肠癌预后评估的有用生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号